With the growth of medicines in Biopharmaceuticals and Biologicals, PharmSol has developed in-house capability for supporting the development, compliance, regulatory and global market access. PharmSol has at its disposal a team of accomplished scientists from Europe.

PharmSol evaluates each biopharmaceutical product and its manufacturing facility in terms of its compliance with IPR, Regulatory and GMP and provides the requisite guidance including Scientific Advice, in meeting the global regulatory requirements. PharmSol manages the entire process of obtaining GMP Certification and Registration of the product in EU, US, Australia, Canada among others, ensuring successful outcomes.